| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/17/2013 | CN102533798B Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof |
| 07/17/2013 | CN101985037B Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 07/17/2013 | CN101855338B WNT pathway stimulation in reprogramming somatic cells |
| 07/17/2013 | CN101502642B Use of hepatitis B virus x protein and encoding gene thereof in preparing medicament for treating cancer of liver |
| 07/17/2013 | CN101397564B Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/17/2013 | CN101087886B Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 07/16/2013 | US8486913 MicroRNA fingerprints during human megakaryocytopoiesis |
| 07/16/2013 | US8486912 MicroRNA fingerprints during human megakaryocytopoiesis |
| 07/16/2013 | US8486910 SnoRNAi-small nucleolar RNA degradation by RNA interference in trypanosomatids |
| 07/16/2013 | US8486909 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| 07/16/2013 | US8486907 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 07/16/2013 | US8486698 Inducing differentiation of an isolated marrow stromal cell into a neuronal cell tissue engineering for use in prevention and treatment of nervous system disorders; regenerative medicine; tissue engineering |
| 07/16/2013 | US8486641 Compositions and methods for diagnosing and treating prostate cancer |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486385 Methods for therapy of neurodegenerative disease of the brain |
| 07/16/2013 | CA2569664C Lipid encapsulated interfering rna |
| 07/16/2013 | CA2551121C Crosslinked hyaluronic acid compositions for tissue augmentation |
| 07/16/2013 | CA2535029C Pharmaceutical compositions and methods for accelerating wound healing |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2477283C Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes |
| 07/16/2013 | CA2476890C Subtilisin carlsberg proteins with reduced immunogenicity |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425486C Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/11/2013 | WO2013103424A2 Silk-based multifunctional biomedical platform |
| 07/11/2013 | WO2013103401A1 Methods and compositions for the treatment of cancer |
| 07/11/2013 | WO2013103146A1 Single-stranded nucleic acid molecule having amino acid backbone |
| 07/11/2013 | WO2013102904A1 Methods and compositions for gene delivery |
| 07/11/2013 | WO2013036031A3 Pharmaceutical composition including a microrna486 expression inhibitor as an active ingredient for preventing and treating neurological disorders |
| 07/11/2013 | WO2013030838A3 Dendrimer-lyotropic liquid crystal (llc) systems |
| 07/11/2013 | US20130178421 Interfering rna delivery system and uses thereof |
| 07/11/2013 | US20130177631 Method and medicament for inhibiting the expression of a given gene |
| 07/11/2013 | US20130177577 Nlrc5 as a target to intervene mhc class 1-mediated immune responses |
| 07/11/2013 | DE102008047781B4 Peptide, die an durch Matrix-Metalloprotease 2 modifiziertes humanes Kollagen IV binden, pharmazeutische Zubereitung und deren Verwendung Peptides that bind to modified by matrix metalloprotease 2 human collagen IV, pharmaceutical preparation and the use thereof |
| 07/10/2013 | EP2612678A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor |
| 07/10/2013 | EP2611920A2 Vesicular stomatitis viruses |
| 07/10/2013 | EP2611467A1 Small liposomes for delivery of immunogen-encoding rna |
| 07/10/2013 | EP2611451A2 Design of oligonucleotide analogs as therapeutic agents |
| 07/10/2013 | CN1671425B ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 07/10/2013 | CN103200959A Combined antigen and DNA vaccine for preventing and treating autoimmune diseases |
| 07/10/2013 | CN103194489A Novel cationic liposome nucleic acid pharmaceutical preparation as well as preparation method and application thereof |
| 07/10/2013 | CN103194475A Enterovirus 71 infectious clone, as well as construction method and application thereof |
| 07/10/2013 | CN103194472A Porcine epizootic diarrhea virus S1 protein fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103194471A Swine transmissible gastroenteritis virus S/N protein fusion gene and recombinant lactococcus lactis, and their use |
| 07/10/2013 | CN103194470A Swine transmissible gastroenteritis virus antigen fusion gene and recombinant bacillus megaterium, and their use |
| 07/10/2013 | CN103193979A Application of hydroxyl-containing crosslinked polymer guanidinated product in gene transfer |
| 07/10/2013 | CN103193885A Anti-EPHRINB2 antiboies and methods using same |
| 07/10/2013 | CN103191445A Use of mesenchymal stem cell and preparation method thereof |
| 07/10/2013 | CN103191444A Method for preparing HPV16L2 recombinant adenovirus vaccine |
| 07/10/2013 | CN103191443A Application of cancer suppressor gene FBXW7 in preparation of drugs used for preventing or treating breast tumors, expression vector and diagnosis medicine |
| 07/10/2013 | CN103191442A Anti-HIV-1-virus tuberculosis gene vaccine, and preparation method and application thereof |
| 07/10/2013 | CN103191413A Novel purpose of OCT4B protein isomer |
| 07/10/2013 | CN102373210B MicroRNA (Ribonucleic Acid) relevant to diabetes mellitus endothelial progenitor cell paralysis and application thereof |
| 07/10/2013 | CN102296078B RNA (Ribose Nucleic Acid) interference targets capable of being used for treating AIDS (Acquired Immune Deficiency Syndrome) |
| 07/10/2013 | CN102203254B SiRNA compositions and methods for potently inhibiting viral infection |
| 07/10/2013 | CN102083878B Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| 07/10/2013 | CN102030754B Non-viral vector, and preparation method and application thereof |
| 07/10/2013 | CN101981185B Double-stranded lipid-modified RNA having high RNA interference effect |
| 07/10/2013 | CN101935650B siRNA (Small interfering Ribonucleic Acid) molecule for interfering Survivin expression and application thereof |
| 07/10/2013 | CN101516385B Treatment of excessive neovascularization |
| 07/09/2013 | US8481508 Ultra-small RNAs as toll-like receptor-3 antagonists |
| 07/09/2013 | US8481506 Nucleic acids involved in viral infection |
| 07/09/2013 | US8481504 Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications |
| 07/09/2013 | US8481317 Hepatocyte production by forward programming |
| 07/09/2013 | US8481055 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/09/2013 | US8481050 Tissue culture system for production of hepatitis C virus |
| 07/09/2013 | US8481026 Bacteria with increased trehalose production and method for using the same in bioremediation |
| 07/09/2013 | US8481023 Oncolytic rhabdovirus |
| 07/09/2013 | US8481022 Method of treating autoimmune disease with mesenchymal stem cells |
| 07/09/2013 | CA2463641C Antisense antiviral agent and method for treating ssrna viral infection |
| 07/09/2013 | CA2445593C Genetically modified yt cell line and use thereof |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/09/2013 | CA2420879C Anti-microbial agents |
| 07/09/2013 | CA2369413C Transmembrane protein expressed in prostate and other cancers |
| 07/09/2013 | CA2354188C Cancer cell vaccine |
| 07/04/2013 | WO2013101690A1 Modified mrnas encoding cell-penetrating polypeptides |
| 07/04/2013 | WO2013059778A3 Antigen presenting cancer vaccine with gamma interferon |
| 07/04/2013 | WO2013049026A4 Neurabin scaffolding of the adenosine receptor and rgs4 regulates anti-seizure effect of endogenous adenosine |
| 07/04/2013 | WO2013048211A3 Apoptosis-inducing composition comprising kaiso protein |
| 07/04/2013 | WO2013036904A3 Methods, agents and peptides for inhibiting matrix metalloproteinase-2 signaling |
| 07/04/2013 | US20130174286 In Vivo Gene Silencing By Chemically Modified and Stable siRNA |
| 07/04/2013 | US20130172405 Compositions and methods for silencing smad4 |
| 07/04/2013 | US20130172403 Gene therapy for sulfatase deficiency |
| 07/04/2013 | US20130172279 Composition for topical treatment of mixed vaginal infections |
| 07/04/2013 | US20130172251 Modified ghrelin peptides |
| 07/04/2013 | US20130171726 Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 07/04/2013 | US20130171107 Long lasting drug formulations |
| 07/04/2013 | CA2861247A1 Antisense nucleic acids |
| 07/03/2013 | EP2609218A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 07/03/2013 | EP2608812A2 Methods targeting mir-33 micrornas for regulating lipid metabolism |
| 07/03/2013 | EP2608801A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
| 07/03/2013 | CN1360678B Method for early detection of flaviviruses using NS1 glycoprotein and application thereof |
| 07/03/2013 | CN103189511A Method for producing novel hiPSC by means of siRNA introduction |
| 07/03/2013 | CN103189507A Adeno-associated virus virions for transferring genes into neural cells |
| 07/03/2013 | CN103184234A Tumor antigens BFA5 for prevention and/or treatment of cancer |
| 07/03/2013 | CN103184223A Si RNA (small interfering RNA) used for supressing tumors and application thereof |
| 07/03/2013 | CN103184202A A pair of short peptides, proteins and polynucleotides, host cells and applications thereof |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |